What's new in hip arthroplasty

Journal of Bone and Joint Surgery

Volumn 85, Issue 9, 2003, Pages 1852-1864

  Huo, Michael H ^a   Brown, Barrett S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM OXIDE; ANALGESIC AGENT; BONE CEMENT; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOGENIC PROTEIN 1; POLYETHYLENE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANIMAL MODEL; ARTHROPLASTY; BLOOD AUTOTRANSFUSION; CERAMICS; EPIDURAL ANESTHESIA; HIP ARTHROPLASTY; HIP SURGERY; HUMAN; INFECTION RATE; JOINT PROSTHESIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; NONHUMAN; OSTEOLYSIS; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; SPINAL ANESTHESIA; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0141521806     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200309000-00041     Document Type: Review

References (35)

1. Lachlewicz PF, Messick P. Precoated femoral component in primary hybrid total hip arthroplasty: results at a mean 10-year follow-up. J Arthroplasty. 2003;18:1-5.
2. Sanchez-Sotelo J, Berry DJ, Harmsen S. Long-term results of use of a collared matte-finished femoral component fixed with second-generation cementing techniques. A fifteen-year-median follow-up study. J Bone Joint Surg Am. 2002;84:1636-41.
3. Iesaka K, Jaffe WL, Kummer FJ. Effects of preheating of hip prostheses on the stem-cement interface. J Bone Joint Surg Am. 2003;85:421-7.
4. Stolk J, Verdonschot N, Hulskes R. Stair climbing is more detrimental to the cement in hip replacement than walking. Clin Orthop. 2002;405:294-305.
5. Laupacis A, Bourne R, Rorabeck C, Feeny D, Tugwell P, Wong C. Comparison of total hip arthroplasty performed with and without cement: a randomized trial. J Bone Joint Surg Am. 2002;84:1823-8.
6. Teloken MA, Bissett G, Hozack WJ, Sharkey PF, Rothman RH. Ten to fifteen-year follow-up after total hip arthroplasty with a tapered cobalt-chromium femoral component (Tri-Lock) inserted without cement. J Bone Joint Surg Am. 2002;84:2140-4.
7. Garcia-Cimbrelo E, Cruz-Pardos A, Madero R, Ortega-Andreu M. Total hip arthroplasty with use of the cementless Zweymüller Alloclassic system. A ten to thirteen-year follow-up study. J Bone Joint Surg Am. 2003;85:296-303.
8. Karrholm J, Anderber C, Snorrason F, Thanner J, Langeland N, Malchau H, Herberts P. Evaluation of a femoral stem with reduced stiffness. A randomized study with use of radiostereometry and bone densitometry. J Bone Joint Surg Am. 2002;84:1651-8.
9. Engh CA Jr, Ellis TJ, Koralewicz LM, McAuley JP, Engh CA Sr. Extensively porous-coated femoral revision for severe femoral bone loss: minimum 10-year follow-up. J Arthroplasty. 2002;17:955-60.
10. Patel JV, Masonls JL, Bourne RB, Rorabeck CH. The fate of cementless jumbo cups in revision hip arthroplasty. J Arthroplasty. 2003;18:129-33.
11. McPherson EJ, Woodson C, Holtom P, Roldis N, Shufelt C, Patzakis M. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop. 2002;403:8-15.
12. Hanssen AD, Osmon DR. Evaluation of a staging system for infected hip arthroplasty. Clin Orthop. 2002;403:16-22.
13. Clerny G 3rd, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop. 2002;403:23-8.
14. Wentworth SJ, Masrl BA, Duncan CP, Southworth CB. Hip prosthesis of antibiotic-loaded acrylic cement for the treatment of infections following total hip arthroplasty. J Bone Joint Surg Am. 2002;84 Suppl 2:123-8.
15. Charlton WP, Hozack WJ, Teloken MA, Rao R, Bissett GA. Complications associated with reimplantation after Girdlestone arthroplasty. Clin Orthop. 2003;407;119-26.
16. Alberton GM, High WA, Morrey BF. Dislocation after revision total hip arthroplasty: an analysis of risk factors and treatment options. J Bone Joint Surg Am. 2002;84:1788-92.
17. Sloen W, Simon JP, Labey L, Van Audekercke R. Posterior transosseous capsulotendinous repair in total hip arthroplasty: a cadaver study. J Bone Joint Surg Am. 2002;84:1793-8.
18. Macaulay W, Westrich G, Sharrock N, Sculco TP, Jhon PH, Peterson MG, Salvati EA. Effect of pneumatic compression on fibrinolysis after total hip arthroplasty. Clin Orthop. 2002;399:168-76.
19. Ryan MG, Westrich GH, Potter HG, Sharrock N, Maun LM, Macaulay W, Katkin P, Sculco TP, Salvati EA. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography. J Bone Joint Surg Am. 2002;84:1998-2004.
20. DiGiola AM 3rd, Plakseychuk AY, Levison TJ, Jaramaz B. Mini-incision technique for total hip arthroplasty with navigation. J Arthroplasty. 2003;18:123-8.
21. Orishimo KF, Sychterz CJ, Hopper RH Jr, Engh CA. Can component and patient factors account for the variance in wear rates among bilateral total hip arthroplasty patients? J Arthroplasty. 2003;18:154-60.
22. Hopper RH Jr, Young AM, Orishimo KF, Engh CA Jr. Effect of terminal sterilization with gas plasma or gamma radiation on wear of polyethylene liners. J Bone Joint Surg Am. 2003;85:464-8.
23. Hul AJ, McCaiden RW, Martell JM, MacDonald SJ, Bourne RB, Rorabeck CH. Validation of two and three-dimensional radiographic techniques for measuring polyethylene wear after total hip arthroplasty. J Bone Joint Surg Am. 2003;85:505-11.
24. Silva MJ, Sandell U. What's new in orthopaedic research. J Bone Joint Surg Am. 2002;84:1490-6.
25. Ulrich-Vinther M, Carmody EE, Goater JJ, Søballe K, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am. 2002;84:1405-12.
26. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am. 2001;83:1789-97.
27. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoll E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States Medicare population. J Bone Joint Surg Am. 2003;85:27-32.
28. Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoll E, Baron JA, Harris WH, Poss R, Katz JN. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 2003;85:20-6.
29. Holtzman J, Saleh K, Kane R. Effect of baseline functional status and pain on outcomes of total hip arthroplasty. J Bone Joint Surg Am. 2002;84:1942-8.
30. McGee MA, Howle DW, Ryan P, Moss JR, Holubowycz OT. Comparison of patient and doctor responses to a total hip arthroplasty clinical evaluation questionnaire. J Bone Joint Surg Am. 2002;84:1745-52.
31. Lieberman JR, Thomas BJ, Finerman GA, Dorey F. Patients' reasons for undergoing total hip arthroplasty can change over time. J Arthroplasty. 2003;18:63-8.
32. Glibey HJ, Ackland TR, Wang AW, Morton AR, Trouchet T, Tapper J. Exercise improves early functional recovery after total hip arthroplasty. Clin Orthop. 2003;408:193-200.
33. Mallory TH, Lombardi AV Jr, Fada RA, Dodds KL, Adams JB. Pain management for joint arthroplasty: preemptive analgesia. J Arthroplasty. 2002;17 (4 Suppl 1):129-33.
34. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am. 2002;84:1299-304.
35. Kim YH, Oh SW, Kim JS. Prevalence of fat embolism following bilateral simultaneous and unilateral total hip arthroplasty performed with or without cement: a prospective, randomized clinical study. J Bone Joint Surg Am. 2002;84:1372-9.